The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and antiparkinsonian-like effects in MPTP-treated marmosets

Ria Fisher; Atsuko Hikima; Rebecca Morris; Michael John Jackson; Sarah Salvage; Mark A Varney; Ronen Depoortere; Adrian Newman-Tancredi

The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and antiparkinsonian-like effects in MPTP-treated marmosets

Ria Fisher, Atsuko Hikima, Rebecca Morris, Michael John Jackson, Sarah Salvage, Mark A Varney, Ronen Depoortere, Adrian Newman-Tancredi

Institute of Pharmaceutical Science

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	https://doi.org/10.1016/j.neuropharm.2020.107997
Journal	Neuropharmacology
Publication status	Published - 10 Feb 2020

Cite this

@article{598df68aaada4962b7fdf065b8c50c9e,

title = "The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and antiparkinsonian-like effects in MPTP-treated marmosets",

author = "Ria Fisher and Atsuko Hikima and Rebecca Morris and Jackson, {Michael John} and Sarah Salvage and Varney, {Mark A} and Ronen Depoortere and Adrian Newman-Tancredi",

year = "2020",

month = feb,

day = "10",

language = "English",

journal = "Neuropharmacology",

issn = "0028-3908",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and antiparkinsonian-like effects in MPTP-treated marmosets

AU - Fisher, Ria

AU - Hikima, Atsuko

AU - Morris, Rebecca

AU - Jackson, Michael John

AU - Salvage, Sarah

AU - Varney, Mark A

AU - Depoortere, Ronen

AU - Newman-Tancredi, Adrian

PY - 2020/2/10

Y1 - 2020/2/10

M3 - Article

SN - 0028-3908

JO - Neuropharmacology

JF - Neuropharmacology

M1 - https://doi.org/10.1016/j.neuropharm.2020.107997

ER -